Claritev Revenue 2019-2026 | CTEV

Claritev revenue from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Claritev Annual Revenue
(Millions of US $)
2025 $965
2024 $931
2023 $962
2022 $1,080
2021 $1,118
2020 $938
2019 $983
2018 $1,041
Claritev Quarterly Revenue
(Millions of US $)
2026-06-30 $257
2026-03-31 $245
2025-12-31 $247
2025-09-30 $246
2025-06-30 $242
2025-03-31 $231
2024-12-31 $232
2024-09-30 $230
2024-06-30 $233
2024-03-31 $235
2023-12-31 $244
2023-09-30 $243
2023-06-30 $238
2023-03-31 $237
2022-12-31 $241
2022-09-30 $250
2022-06-30 $290
2022-03-31 $298
2021-12-31 $298
2021-09-30 $288
2021-06-30 $276
2021-03-31 $255
2020-12-31 $255
2020-09-30 $224
2020-06-30 $207
2020-03-31 $252
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.618B $0.965B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.014B 42.92
Tempus AI (TEM) United States $11.225B 0.00
10x Genomics (TXG) United States $9.135B 0.00
Hinge Health (HNGE) United States $7.649B 73.48
Hims & Hers Health (HIMS) United States $6.722B 0.00
Doximity (DOCS) United States $4.704B 29.00
Heartflow (HTFL) United States $4.308B 0.00
IRhythm Holdings (IRTC) United States $3.782B 249.39
Clover Health Investments (CLOV) United States $2.709B 0.00
Privia Health (PRVA) United States $2.667B 99.43
Inspire Medical Systems (INSP) United States $2.149B 32.74
Butterfly Network (BFLY) United States $1.973B 0.00
Schrodinger (SDGR) United States $1.532B 0.00
Omnicell (OMCL) United States $1.524B 21.76
Azenta (AZTA) United States $1.404B 76.29
Enovis (ENOV) United States $1.051B 5.44
Talkspace (TALK) United States $0.879B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.659B 0.00
Phreesia (PHR) United States $0.647B 34.73
Veradigm (MDRX) United States $0.593B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Evolent Health (EVH) United States $0.464B 0.00
Carlsmed (CARL) United States $0.419B 0.00
Senseonics Holdings (SENS) United States $0.370B 0.00
CapsoVision (CV) United States $0.326B 0.00
Standard BioTools (LAB) United States $0.273B 0.00
American Well (AMWL) United States $0.230B 0.00
KORU Medical Systems (KRMD) United States $0.144B 0.00
Health Catalyst (HCAT) United States $0.137B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.132B 0.00
CareCloud (CCLD) United States $0.089B 6.53
Pulmonx (LUNG) United States $0.085B 0.00
Zepp Health (ZEPP) Netherlands $0.065B 0.00
Nyxoah SA (NYXH) Belgium $0.062B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
Outset Medical (OM) United States $0.059B 0.00
EUDA Health Holdings (EUDA) Singapore $0.050B 0.00
Precipio (PRPO) United States $0.049B 0.00
MDxHealth SA (MDXH) Belgium $0.035B 0.00
111 (YI) China $0.031B 0.00
Evaxion - (EVAX) Denmark $0.026B 0.00
HeartBeam (BEAT) United States $0.023B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
HeartSciences (HSCS) United States $0.014B 0.00
Healthcare Triangle (HCTI) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.009B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
DataMeds AI (MEDS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
Zhongchao (ZCMD) China $0.001B 0.00
TruBridge (TBRG) United States $0.000B 0.00